1225 related articles for article (PubMed ID: 15853009)
1. [Ultrasound screening for Down syndrome and other chromosomal abnormalities by fetal nuchal translucency measurement between 11-14 weeks of gestation].
Dimitrova V; Markov D; Chernev T; Karag'ozova Zh; Mazneĭkova V; Andonova S; Vŭzharova R
Akush Ginekol (Sofiia); 2005; 44(1):32-7. PubMed ID: 15853009
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
3. [First trimester ultrasound screening for structural and chromosomal anomalies in multiple pregnancy].
Markov D; Chernev T; Dimitrova V; Masneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
Akush Ginekol (Sofiia); 2004; 43(5):11-8. PubMed ID: 15518278
[TBL] [Abstract][Full Text] [Related]
4. [Ultrasound screening and diagnosis of fetal structural abnormalities between 11-14 gestational weeks].
Markov D; Chernev T; Dimitrova V; Mazneĭkova V; Leroy Y; Jacquemyn Y; Ramaekers P; Van Bulck B; Loquet P
Akush Ginekol (Sofiia); 2004; 43(3):3-10. PubMed ID: 15341249
[TBL] [Abstract][Full Text] [Related]
5. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years experience.
Spencer K; Nicolaides KH
BJOG; 2003 Mar; 110(3):276-80. PubMed ID: 12628267
[TBL] [Abstract][Full Text] [Related]
6. [Study on several ultrasound markers combined maternal serum biochemical markers to screen fetal chromosomal aneuploidy at 11 to 13(+)6 weeks of gestation].
Chen X; Chang Y; Cui HY; Ren CC; Yu BY
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):815-8. PubMed ID: 24444556
[TBL] [Abstract][Full Text] [Related]
7. Prenatal screening for and diagnosis of aneuploidy in twin pregnancies.
Audibert F; Gagnon A; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):754-67. PubMed ID: 21749753
[TBL] [Abstract][Full Text] [Related]
8. Screening for Down syndrome based on maternal age or fetal nuchal translucency: a randomized controlled trial in 39,572 pregnancies.
Saltvedt S; Almström H; Kublickas M; Valentin L; Bottinga R; Bui TH; Cederholm M; Conner P; Dannberg B; Malcus P; Marsk A; Grunewald C
Ultrasound Obstet Gynecol; 2005 Jun; 25(6):537-45. PubMed ID: 15912479
[TBL] [Abstract][Full Text] [Related]
9. Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A.
Kagan KO; Wright D; Baker A; Sahota D; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jun; 31(6):618-24. PubMed ID: 18461550
[TBL] [Abstract][Full Text] [Related]
10. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination.
Dick PT
CMAJ; 1996 Feb; 154(4):465-79. PubMed ID: 8630836
[TBL] [Abstract][Full Text] [Related]
11. First-trimester combined ultrasound and biochemical screening for Down syndrome in routine clinical practice.
Stenhouse EJ; Crossley JA; Aitken DA; Brogan K; Cameron AD; Connor JM
Prenat Diagn; 2004 Oct; 24(10):774-80. PubMed ID: 15503268
[TBL] [Abstract][Full Text] [Related]
12. Screening for trisomy 21 by maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a German multicenter study.
von Kaisenberg CS; Gasiorek-Wiens A; Bielicki M; Bahlmann F; Meyberg H; Kossakiewicz A; Pruggmayer M; Kamin G; Fritzer E; Harris C; Arnold N;
J Matern Fetal Neonatal Med; 2002 Aug; 12(2):89-94. PubMed ID: 12420837
[TBL] [Abstract][Full Text] [Related]
13. Prospective evaluation of a first trimester screening program for Down syndrome and other chromosomal abnormalities using maternal age, nuchal translucency and biochemistry in an Australian population.
Scott F; Peters H; Bonifacio M; McLennan A; Boogert A; Kesby G; Anderson J
Aust N Z J Obstet Gynaecol; 2004 Jun; 44(3):205-9. PubMed ID: 15191443
[TBL] [Abstract][Full Text] [Related]
14. Screening for trisomy 21 with maternal age, fetal nuchal translucency and maternal serum biochemistry at 11-14 weeks: a regional experience from Germany.
Soergel P; Pruggmayer M; Schwerdtfeger R; Muhlhaus K; Scharf A
Fetal Diagn Ther; 2006; 21(3):264-8. PubMed ID: 16601335
[TBL] [Abstract][Full Text] [Related]
15. [Ultrasound screening for chromosomal anomalies by assessment of the fetal nasal bone during 11-14 weeks of gestation--a pilot study].
Markov D; Dimitrova V
Akush Ginekol (Sofiia); 2008; 47(1):3-9. PubMed ID: 18642566
[TBL] [Abstract][Full Text] [Related]
16. Screening for trisomy 21 by fetal tricuspid regurgitation, nuchal translucency and maternal serum free beta-hCG and PAPP-A at 11 + 0 to 13 + 6 weeks.
Falcon O; Auer M; Gerovassili A; Spencer K; Nicolaides KH
Ultrasound Obstet Gynecol; 2006 Feb; 27(2):151-5. PubMed ID: 16388509
[TBL] [Abstract][Full Text] [Related]
17. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10-14 weeks of gestation. Fetal Medicine Foundation First Trimester Screening Group.
Snijders RJ; Noble P; Sebire N; Souka A; Nicolaides KH
Lancet; 1998 Aug; 352(9125):343-6. PubMed ID: 9717920
[TBL] [Abstract][Full Text] [Related]
18. Screening for chromosomal abnormalities in the first trimester using ultrasound and maternal serum biochemistry in a one-stop clinic: a review of three years prospective experience.
Spencer K; Spencer CE; Power M; Dawson C; Nicolaides KH
BJOG; 2003 Mar; 110(3):281-6. PubMed ID: 12628268
[TBL] [Abstract][Full Text] [Related]
19. Improved first-trimester Down syndrome screening performance by lowering the false-positive rate: a prospective study of 9941 low-risk women.
Wøjdemann KR; Shalmi AC; Christiansen M; Larsen SO; Sundberg K; Brocks V; Bang J; Nørgaard-Pedersen B; Tabor A
Ultrasound Obstet Gynecol; 2005 Mar; 25(3):227-33. PubMed ID: 15736185
[TBL] [Abstract][Full Text] [Related]
20. [OSCAR (one-stop clinic for assessment of fetal risk): our experience with first trimester screening for chromosomal abnormalities].
Dhaifalah I; Vrbická D; Santavý J
Ceska Gynekol; 2006 Sep; 71(5):363-9. PubMed ID: 17131919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
